[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Jason Ahee, M.D.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100304506",false,"NCT03244072","Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery","Safety and Efficacy of Intracameral Zimoxin (0.1% Moxifloxacin Solution) for Prevention of Endophthalmitis After Cataract Surgery","Inclusion Criteria:\n\n* visually significant cataracts\n\nExclusion Criteria:\n\n* allergy to fluoroquinolones, cobalamin (B12)",true,"ALL","40 Years",{"count":19,"type":20},60000,"ESTIMATED","INTERVENTIONAL",[23,24],"PHASE2","PHASE3","Intracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis",[27],"Endophthalmitis","NOT_YET_RECRUITING","2025-09-21",{"date":31,"type":32},"2025-09-25","ACTUAL",{"date":34,"type":20},"2026-06-01",{"date":36,"type":20},"2031-10",{"name":38,"class":39},"Jason Ahee, M.D.","INDUSTRY",""]